Bukhari Mulazim Hussain, Niazi Shahida, Khan Saeed Akhter, Hashmi Ihsanulla, Perveen Shahida, Qureshi Shahzad Shafqat, Chaudhry Naseer Ahmed, Qureshi G R, Hasan Mumtaz
Department of Pathology and Medicine, King Edward Medical University and Mayo Hospital, Lahore, Pakistan.
Int J Exp Pathol. 2007 Feb;88(1):47-53. doi: 10.1111/j.1365-2613.2006.00522.x.
This study was conducted in the department of Pathology King Edward Medical University, from June to December 2002 to introduce the new method of AgNOR staining and its interpretation to increase its reliability. A total of 60 brain specimens were stained with modified AgNOR technique. The diagnosis of malignancy was made on H & E staining. AgNOR counts, variation in size and dispersion of AgNOR dots in cells were graded and compared in malignant and non-malignant lesions. Modified method of AgNOR staining and interpretation was an easy, reliable and reproducible alternative to traditional AgNOR techniques for evaluating proliferation activity of cells in malignant and benign brain lesions. mAgNOR counts of different grades of astrocytoma (2.97+/-0.96, 3.97+/-0.43, 6.01+/-2.74 and 8.01+/-3.56) were significantly (P<0.01) greater when compared with counts of normal brain (0.40+/-0.01), and reactive gliosis (0.60+/-0.01). AgNOR size and dispersion were of higher grade in a significantly greater proportion of malignancy when compared with benign conditions (P<0.05). The AgNOR dots were brighter and more clear with modified staining when compared with previous studies. We conclude that modified AgNOR staining technique is simple, quick and reliable to evaluate cell proliferation by detecting AgNORs size and dispersion. In future, AgNOR size and dispersion should be considered rather than the count only. We recommend the use of morphometry for AgNOR size in future. We also recommend the use of modified AgNOR staining for obtaining sound and confidant results in routine paraffin sections.
本研究于2002年6月至12月在爱德华国王医科大学病理科进行,旨在引入银染核仁组织区(AgNOR)染色的新方法及其解读方式,以提高其可靠性。总共60份脑标本采用改良的AgNOR技术进行染色。通过苏木精和伊红(H&E)染色做出恶性肿瘤诊断。对恶性和非恶性病变中的AgNOR计数、AgNOR点在细胞中的大小变化和分散情况进行分级并比较。改良的AgNOR染色和解读方法是一种简便、可靠且可重复的替代传统AgNOR技术的方法,用于评估恶性和良性脑病变中细胞的增殖活性。不同级别的星形细胞瘤的改良AgNOR计数(2.97±0.96、3.97±0.43、6.01±2.74和8.01±3.56)与正常脑(0.40±0.01)和反应性胶质增生(0.60±0.01)的计数相比,显著更高(P<0.01)。与良性病变相比,AgNOR大小和分散在恶性病变中的比例显著更高(P<0.05)。与先前的研究相比,改良染色后的AgNOR点更亮、更清晰。我们得出结论,改良的AgNOR染色技术通过检测AgNOR的大小和分散情况来评估细胞增殖简单、快速且可靠。未来,应考虑AgNOR的大小和分散情况,而不仅仅是计数。我们建议未来对AgNOR大小使用形态计量学方法。我们还建议在常规石蜡切片中使用改良的AgNOR染色以获得可靠且令人信服的结果。